Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients

BACKGROUND: In the past, multiple sclerosis (MS) medications have been primarily designed to modulate T cell properties. Based on the emerging concept that B cells are equally important for the propagation of MS, we compared the effect of four commonly used, primarily T cell-targeting MS medications...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Neuroinflammation
Prif Awduron: Traub, Jan W., Pellkofer, Hannah L., Grondey, Katja, Seeger, Ira, Rowold, Christoph, Brück, Wolfgang, Husseini, Leila, Häusser-Kinzel, Silke, Weber, Martin S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858649/
https://ncbi.nlm.nih.gov/pubmed/31733652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-019-1593-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg